Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 253,500 KRW
Change Today -5,000.00 / -1.93%
Volume 87.4K
000100 On Other Exchanges
Symbol
Exchange
Korea SE
Korea SE
As of 2:23 AM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

yuhan corp (000100) Snapshot

Open
262,000
Previous Close
258,500
Day High
264,500
Day Low
249,000
52 Week High
05/21/15 - 300,000
52 Week Low
01/8/15 - 162,500
Market Cap
2.8T
Average Volume 10 Days
62.4K
EPS TTM
9,161
Shares Outstanding
11.2M
EX-Date
12/29/14
P/E TM
27.7x
Dividend
1,750
Dividend Yield
0.69%
Current Stock Chart for YUHAN CORP (000100)

Related News

No related news articles were found.

yuhan corp (000100) Related Businessweek News

No Related Businessweek News Found

yuhan corp (000100) Details

Yuhan Corporation operates as a pharmaceutical company in South Korea. The company offers Revanex, an acid pump antagonist; and active pharmaceutical ingredients and intermediates in the areas of antiviral, antibiotic, anti-inflammatory, hepatotropic, anti-thrombotic, anti-ulcer, anti-diabetic, anti-hyperlipidemics, anti-HIV, anti-HCV, anti-histamine, ß-lactamase inhibitors, CNS intermediates, PEG-compounds, and others. It also provides ETC products in various areas comprising cardiovascular, metabolic, respiratory and allergy, alimentary, genito-urinary, and neuro systems; anti-cancer, anti-viral, and anti-infective diseases; and analgesics, antirheumatics, anesthetics, and dermatologics. In addition, the company offers OTC products in the areas of vitamins and minerals, hepatopathy drugs and tonics, respiratory and alimentary systems, dermatologics and analgesics, and others; and contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

Founded in 1926

yuhan corp (000100) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

yuhan corp (000100) Key Developments

Yuhan Corp., Annual General Meeting, Mar 20, 2015

Yuhan Corp., Annual General Meeting, Mar 20, 2015., at 10:00 Korea Standard Time. Location: Dongjak 74 Yuhan. Agenda: To consider the earnings results for the year ended December 31, 2014; to consider the election of directors and appointment of audit committee; and to consider the appointment of standing auditor.

Yuhan Corp. to Report Fiscal Year 2014 Results on Feb 25, 2015

Yuhan Corp. announced that they will report fiscal year 2014 results on Feb 25, 2015

Yuhan Corp. to Report Nine Months, 2014 Results on Oct 28, 2014

Yuhan Corp. announced that they will report nine months, 2014 results on Oct 28, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000100:KS 253,500.00 KRW -5,000.00

000100 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000100.
View Industry Companies
 

Industry Analysis

000100

Industry Average

Valuation 000100 Industry Range
Price/Earnings 28.2x
Price/Sales 2.6x
Price/Book 2.1x
Price/Cash Flow 29.9x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YUHAN CORP, please visit www.yuhan.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.